Clinical research studies seek to advance and improve treatment options for a variety of conditions, including IgA nephropathy (IgAN).
They are designed to answer questions about the safety and effectiveness of potential new medications.
Quick Facts
Clinical research studies must be performed before a new medication or treatment can be approved for use and made available to the public.
There are common traits that people must have to participate in a study, called eligibility criteria. Common criteria include age, sex, medical history, and other medical conditions.
Right now, there are more than 500,000 research studies registered around the world looking at a variety of health conditions.1
People’s backgrounds—like age, sex or gender, ancestry or ethnicity, disability, and where they live—can affect how they respond to medicines. When many different people join clinical research, we learn how a medicine works across populations.
